SG Americas Securities’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,161
| Closed | -$15K | – | 2817 |
|
|
2025
Q1 | $15K | Buy |
16,161
+227
| +1% | +$211 | ﹤0.01% | 2967 |
|
|
2024
Q4 | $44K | Buy |
15,934
+477
| +3% | +$1.32K | ﹤0.01% | 2590 |
|
|
2024
Q3 | $81K | Buy |
+15,457
| New | +$81K | ﹤0.01% | 2783 |
|
|
2024
Q2 | – | Sell |
-13,926
| Closed | -$107K | – | 2611 |
|
|
2024
Q1 | $107K | Sell |
13,926
-7,310
| -34% | -$56.2K | ﹤0.01% | 2224 |
|
|
2023
Q4 | $90K | Buy |
21,236
+6,784
| +47% | +$28.8K | ﹤0.01% | 2559 |
|
|
2023
Q3 | $61K | Buy |
+14,452
| New | +$61K | ﹤0.01% | 2608 |
|
|
2021
Q4 | – | Sell |
-11,611
| Closed | -$135K | – | 3151 |
|
|
2021
Q3 | $135K | Buy |
+11,611
| New | +$135K | ﹤0.01% | 3228 |
|